A busy week in Washington, D.C., brought legislation to fix the Inflation Reduction Act “pill penalty,” bipartisan calls for PBM reform, and BIO CEO John F. Crowley explaining why Congress needs to ...

WASHINGTON D.C. (February 25, 2025) – John Crowley, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after Representatives Gregory Murphy (R-NC), ...

We’re getting ready for Rare Disease Day (February 28) with a look at how policy can support patients and how BIO is engaging with the FDA. (960 words, 4 minutes, 48 seconds) Ahead of Rare Disease Day ...

A collaborative initiative to advance corporate board diversity through partnerships and more.

BIO is committed to providing access to talent, access to capital, and building trust with consumers and patients. BIO Board Initiative A collaborative initiative to advance corporate board diversity ...